Ind-Swift Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 524652 |
NSE Symbol : INDSWFTLTD |
P/E(TTM) : 2.86 |
ISIN Demat : INE788B01028 |
Div & Yield% : - |
EPS(TTM) : 10.14 |
Book Value(₹) : -121.57 |
Market Cap(₹Cr) : 156.97 |
Face Value(₹) : 2.00 |
Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|---|---|
Gross Sales | 136.35 | 113.85 | 135.23 | 102.56 | 115.92 | 148.54 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 136.35 | 113.85 | 135.23 | 102.56 | 115.92 | 148.54 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 4.63 | 39.93 | 46.59 | 2.62 | 3.15 | 5.63 |
Total Income | 140.97 | 153.78 | 181.82 | 105.18 | 119.07 | 154.17 |
Total Expenditure | 121.94 | 110.63 | 120.75 | 98.07 | 104.78 | 130.14 |
PBIDT | 19.03 | 43.15 | 61.08 | 7.11 | 14.29 | 24.03 |
Interest | 9.53 | 9.54 | 14.43 | 15.30 | 18.26 | 14.95 |
PBDT | 9.51 | 33.61 | 46.65 | -8.19 | -3.97 | 9.08 |
Depreciation | 5.39 | 5.37 | 6.88 | 6.78 | 6.73 | 6.72 |
Tax | 0.00 | 0.00 | 2.23 | 0.00 | 0.00 | 0.00 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Reported Profit After Tax | 4.11 | 28.24 | 37.54 | -14.97 | -10.71 | 2.36 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 4.11 | 28.24 | 37.54 | -14.97 | -10.71 | 2.36 |
EPS (Unit Curr.) | 0.76 | 5.21 | 6.93 | -2.76 | -1.98 | 0.44 |
EPS (Adj) (Unit Curr.) | 0.76 | 5.21 | 6.93 | -2.76 | -1.98 | 0.44 |
Calculated EPS (Unit Curr.) | 0.76 | 5.21 | 6.93 | -2.76 | -1.98 | 0.44 |
Calculated EPS (Adj) (Unit Curr.) | 0.76 | 5.21 | 6.93 | -2.76 | -1.98 | 0.44 |
Calculated EPS (Ann.) (Unit Curr.) | 3.04 | 20.85 | 27.72 | -11.05 | -7.91 | 1.74 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 3.04 | 20.85 | 27.72 | -11.05 | -7.91 | 1.74 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 10.83 | 10.83 | 10.83 | 10.83 | 10.83 | 10.83 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 13.96 | 37.90 | 45.17 | 6.93 | 12.33 | 16.18 |
PBDTM(%) | 6.97 | 29.52 | 34.50 | -7.99 | -3.42 | 6.11 |
PATM(%) | 3.01 | 24.80 | 27.76 | -14.60 | -9.24 | 1.59 |